Filing Flows

Filing Flows › Companies › Aveanna Healthcare Holdings › Cash flow

Aveanna Healthcare Holdings cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow$80.9M in Q2 2026 · $168M over twelve months

Operating cash flow$80.9M
Free cash flow+$80.9M
Cash / net income2.0×

Analysis

In Q2 2026, Aveanna Healthcare Holdings generated $80.9M of operating cash flow.

Over the twelve months to Jul 4, 2026, operating cash flow was $168M; the largest uses were acquisitions ($169M), other investing ($14.4M), net borrowing (+) / repaid (−) ($9.8M); besides operations, cash came from other financing ($21.1M), shares issued ($817K); the cash balance fell by $3.5M.

Operating cash flow was $80.9M against net income of $40.3M — 2.0× profit, cash ran ahead of reported earnings. The largest differences: employee-related liabilities +$18.6M, receivables +$6.5M, stock-based pay +$4.1M.

Free cash flow

Aveanna Healthcare Holdings: free cash flow by quarterAveanna Healthcare Holdings: free cash flow by quarter$29.4MQ3 2024$13.4MQ4 2024−$8.6MQ1 2025$51.6MQ2 2025$33.2MQ3 2025$49.7MQ4 2025$4.3MQ1 2026$80.9MQ2 2026
Operating cash flow less capital spending.
Aveanna Healthcare Holdings: operating cash flow against capital spendingAveanna Healthcare Holdings: operating cash flow against capital spendingOperating cash flowCapital spending$29.4M$0Q3 2024$13.4M$0Q4 2024−$8.6M$0Q1 2025$51.6M$0Q2 2025$33.2M$0Q3 2025$49.7M$0Q4 2025$4.3M$0Q1 2026$80.9M$0Q2 2026
Latest (Q2 2026): Operating cash flow $80.9M, Capital spending $0.

Capital allocation, year by year

Aveanna Healthcare Holdings: where the cash came from (up) and went (down), by fiscal yearAveanna Healthcare Holdings: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsFY2021: Operating cash flow −$11.3MFY2021: Net borrowing $1.3BFY2021: Shares issued $479MFY2021: Capital spending −$15.9MFY2021: Acquisitions −$667M$1.8BFY2021FY2022: Operating cash flow −$48.4MFY2022: Net borrowing $49.8MFY2022: Shares issued $4.0MFY2022: Asset sales $460KFY2022: Acquisitions −$2.0M$54.3MFY2022FY2023: Operating cash flow $22.7MFY2023: Net borrowing $10.2MFY2023: Shares issued $945K$33.8MFY2023FY2024: Operating cash flow $32.6MFY2024: Net borrowing −$6.6M$32.6MFY2024FY2025: Operating cash flow $126MFY2025: Net borrowing $1.3BFY2025: Shares issued $212KFY2025: Acquisitions −$14.9M$1.4BFY2025
Over these 5 years operating cash flow totalled $121M; the largest uses were acquisitions ($684M) and operating cash flow ($59.8M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$97.2M
Debt$1.3B
Net debt$1.2B
Due within a year$13.2M

Aveanna Healthcare Holdings funds itself: free cash flow was $168M over the last twelve months, and $97.2M of cash and investments stands against $1.3B of debt ($13.2M due within a year, 7.3× covered by cash).

Aveanna Healthcare Holdings: debt maturities by year (FY2025)Aveanna Healthcare Holdings: debt maturities by year (FY2025)$13.2MYear 1$13.2MYear 2$13.2MYear 3$13.2MYear 4$13.2MYear 5$1.3BAfter year 5
Principal due in each year as disclosed in the annual report, against $97.2M of cash and investments now.

Where the cash came from and went

Aveanna Healthcare Holdings: sources (+) and uses (−) of cash, Q2 2026Aveanna Healthcare Holdings: sources (+) and uses (−) of cash, Q2 2026Other investing−$175MCash drawn (+) / kept (−)$92.1MOperating cash flow$80.9MOther financing$4.6MNet borrowing (+) / repaid (−)−$2.6MShares issued$336K
Aveanna Healthcare Holdings: sources (+) and uses (−) of cash, TTM to Q2 2026Aveanna Healthcare Holdings: sources (+) and uses (−) of cash, TTM to Q2 2026Acquisitions−$169MOperating cash flow$168MOther financing$21.1MOther investing−$14.4MNet borrowing (+) / repaid (−)−$9.8MCash drawn (+) / kept (−)$3.5MShares issued$817K

From profit to cash

Aveanna Healthcare Holdings: net income to operating cash flow, Q2 2026Aveanna Healthcare Holdings: net income to operating cash flow, Q2 2026Net income$40.3MDepreciation & amortization$2.8MStock-based pay$4.1MReceivables$6.5MPayables−$2.5MEmployee-related liabilities$18.6MPrepaid and other assets$2.6MOther operating capital−$2.9MOperating cash flow$80.9M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026$80.9M−$2.6M$336K$92.1M$80.9M
Q1 2026$4.3M−$2.4M$269K$4.0M$4.3M
Q4 2025$49.7M−$3.0M$2.4M−$47.4M$49.7M
Q3 2025$33.2M−$1.8M$2.2M−$45.1M$33.2M
Q2 2025$51.6M−$1.3M—−$29.2M$51.6M
Q1 2025−$8.6M−$2.8M—$12.8M−$8.6M
Q4 2024$13.4M−$2.0M$1K−$5.8M$13.4M
Q3 2024$29.4M−$1.0M$1.7M−$30.8M$29.4M

Aveanna Healthcare Holdings: income statement and cash flow

Aveanna Healthcare Holdings, Q2 2026: revenue $670M (+14% year over year), operating margin 11.9%. The chart follows the revenue to costs, profit and cash.

Aveanna Healthcare Holdings: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.